NHS England unveils new Innovative Medicines Fund
NHS England has launched its new Innovative Medicines Fund (IMF). [...]
The link between physical exercise and cancer
Physical activity has many benefits, including increasing the chance of [...]
Open letter from cancer charities to the public
Forty (40) charities and organisations have written an open letter, [...]
Stereotactic radiotherapy with immunotherapy or targeted therapy for metastatic kidney cancer
This study looked at the safety and effectiveness of targeted [...]
Positive margins after partial nephrectomy and risk of recurrence in kidney cancer
In this meta-analysis, the results from 101,153 patients with renal [...]
ARO-HIF2 shows promise for advanced kidney cancer
A small phase 1b study of a new medicine called [...]
Lenvatinib plus pembrolizumab in for untreated and previously treated metastatic kidney cancer
Results from a phase Ib/II study looking at lenvatinib plus [...]
Survey finds kidney cancer patients face anxiety over delayed scan results
A survey by Kidney Cancer UK involving 77 kidney cancer [...]
Most vulnerable people could be offered a COVID vaccine booster in September
The Joint Committee on Vaccination and immunisation (JVCI) have given [...]
